{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:35:48Z","timestamp":1789349748638,"version":"build-2803163510"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s11883-006-0081-1","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T11:44:53Z","timestamp":1181043893000},"page":"252-260","source":"Crossref","is-referenced-by-count":57,"title":["Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury"],"prefix":"10.1007","volume":"8","author":[{"given":"Neeta","family":"Adhikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"81_CR1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1517\/14622416.5.7.949","volume":"5","author":"SK Ganesh","year":"2004","unstructured":"Ganesh SK, Skelding KA, Mehta L, et al.: Rationale and study design of the CardioGene Study: genomics of instent restenosis. Pharmacogenomics 2004, 5:952\u20131004.","journal-title":"Pharmacogenomics"},{"key":"81_CR2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","volume":"25","author":"MP Winther de","year":"2005","unstructured":"de Winther MP, Kanters E, Kraal G, Hofker MH: Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005, 25:904\u2013914.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR3","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/01.ATV.0000186181.19909.a6","volume":"25","author":"DT Bolick","year":"2005","unstructured":"Bolick DT, Orr AW, Whetzel A, et al.: 12\/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 2005, 25:2301\u20132307.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR4","first-page":"30","volume":"1736","author":"K Lotzer","year":"2005","unstructured":"Lotzer K, Funk CD, Habenicht AJ: The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 2005, 1736:30\u201337.","journal-title":"Biochim Biophys Acta"},{"key":"81_CR5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/hq0901.095278","volume":"21","author":"R Natarajan","year":"2001","unstructured":"Natarajan R, Reddy MA, Malik KU, et al.: Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001, 21:1408\u20131413.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI118598","volume":"97","author":"K Brand","year":"1996","unstructured":"Brand K, Page S, Rogler G, et al.: Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996, 97:1715\u20131722.","journal-title":"J Clin Invest"},{"key":"81_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(01)00546-9","volume":"160","author":"SH Wilson","year":"2002","unstructured":"Wilson SH, Best PJ, Edwards WD, et al.: Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 2002, 160:147\u2013153.","journal-title":"Atherosclerosis"},{"key":"81_CR8","first-page":"1085","volume":"151","author":"DB Landry","year":"1997","unstructured":"Landry DB, Couper LL, Bryant SR, Lindner V: Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 1997, 151:1085\u20131095.","journal-title":"Am J Pathol"},{"key":"81_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000028039","volume":"66","author":"V Lindner","year":"1998","unstructured":"Lindner V: The NF-kappaB and IkappaB system in injured arteries. Pathobiology 1998, 66:311\u2013320.","journal-title":"Pathobiology"},{"key":"81_CR10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0008-6363(01)00535-1","volume":"53","author":"M Rodriguez-Porcel","year":"2002","unstructured":"Rodriguez-Porcel M, Lerman LO, Holmes DR Jr, et al.: Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res 2002, 53:1010\u20131018.","journal-title":"Cardiovasc Res"},{"key":"81_CR11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1248\/bpb.28.1630","volume":"28","author":"R Lin","year":"2005","unstructured":"Lin R, Liu J, Peng N, et al.: Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells. Biol Pharm Bull 2005, 28:1630\u20131634.","journal-title":"Biol Pharm Bull"},{"key":"81_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.ATV.0000150418.14698.75","volume":"25","author":"Z Guan","year":"2005","unstructured":"Guan Z, Basi D, Li Q, et al.: Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis. Arterioscler Thromb Vasc Biol 2005, 25:96\u2013101.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/hh1201.091796","volume":"88","author":"JL Hall","year":"2001","unstructured":"Hall JL, Wang X, Van A, et al.: Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappaB-independent and -dependent pathways. Circ Res 2001, 88:1247\u20131253.","journal-title":"Circ Res"},{"key":"81_CR14","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","volume":"112","author":"E Kanters","year":"2003","unstructured":"Kanters E, Pasparakis M, Gijbels MJ, et al.: Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003, 112:1176\u20131185.","journal-title":"J Clin Invest"},{"key":"81_CR15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-05-1450","volume":"103","author":"E Kanters","year":"2004","unstructured":"Kanters E, Gijbels MJ, van der Made I, et al.: Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 2004, 103:934\u2013940.","journal-title":"Blood"},{"key":"81_CR16","first-page":"483","volume":"56","author":"J Jawien","year":"2005","unstructured":"Jawien J, Gajda M, Mateuszuk L, et al.: Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE\/LDLR-double knockout mice. J Physiol Pharmacol 2005, 56:483\u2013489.","journal-title":"J Physiol Pharmacol"},{"key":"81_CR17","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1074\/jbc.M006922200","volume":"276","author":"SH Lee","year":"2001","unstructured":"Lee SH, Schloss DJ, Jarvis L, et al.: Inhibition of angiogenesis by a mouse sprouty protein. J Biol Chem 2001, 276:4128\u20134133.","journal-title":"J Biol Chem"},{"key":"81_CR18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.CIR.0000125742.65841.8B","volume":"109","author":"XY Zhu","year":"2004","unstructured":"Zhu XY, Rodriguez-Porcel M, Bentley MD, et al.: Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 2004, 109:2109\u20132115.","journal-title":"Circulation"},{"key":"81_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/hc0402.104119","volume":"105","author":"SH Wilson","year":"2002","unstructured":"Wilson SH, Herrmann J, Lerman LO, et al.: Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002, 105:415\u2013418.","journal-title":"Circulation"},{"key":"81_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/146288401316922625","volume":"4","author":"S Fuchs","year":"2001","unstructured":"Fuchs S, Kornowski R, Leon MB, Epstein SE: Anti-angiogenesis: a new potential strategy to inhibit restenosis. Int J Cardiovasc Intervent 2001, 4:3\u20136.","journal-title":"Int J Cardiovasc Intervent"},{"key":"81_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/89068","volume":"7","author":"HJ Duckers","year":"2001","unstructured":"Duckers HJ, Boehm M, True AL, et al.: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001, 7:693\u2013698.","journal-title":"Nat Med"},{"key":"81_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/B:REMD.0000032413.88756.ee","volume":"5","author":"F Blaschke","year":"2004","unstructured":"Blaschke F, Bruemmer D, Law RE: Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis. Rev Endocr Metab Disord 2004, 5:249\u2013254.","journal-title":"Rev Endocr Metab Disord"},{"key":"81_CR23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)65341-2","volume":"154","author":"FS Santiago","year":"1999","unstructured":"Santiago FS, Lowe HC, Day FL, et al.: Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am J Pathol 1999, 154:937\u2013944.","journal-title":"Am J Pathol"},{"key":"81_CR24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0002-9440(10)65233-9","volume":"155","author":"ES Silverman","year":"1999","unstructured":"Silverman ES, Khachigian LM, Santiago FS, et al.: Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury. Am J Pathol 1999, 155:1311\u20131317.","journal-title":"Am J Pathol"},{"key":"81_CR25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0002-9440(10)65312-6","volume":"154","author":"ES Silverman","year":"1999","unstructured":"Silverman ES, Collins T: Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 1999, 154:665\u2013670.","journal-title":"Am J Pathol"},{"key":"81_CR26","doi-asserted-by":"crossref","first-page":"39039","DOI":"10.1074\/jbc.M005159200","volume":"275","author":"B Du","year":"2000","unstructured":"Du B, Fu C, Kent KC, et al.: Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J Biol Chem 2000, 275:39039\u201339047.","journal-title":"J Biol Chem"},{"key":"81_CR27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1172\/JCI8592","volume":"105","author":"TA McCaffrey","year":"2000","unstructured":"McCaffrey TA, Fu C, Du B, et al.: High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 2000, 105:653\u2013662.","journal-title":"J Clin Invest"},{"key":"81_CR28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jcb.10057","volume":"84","author":"RG Fahmy","year":"2002","unstructured":"Fahmy RG, Khachigian LM: Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury. J Cell Biochem 2002, 84:575\u2013582.","journal-title":"J Cell Biochem"},{"key":"81_CR29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/hh2001.097867","volume":"89","author":"HC Lowe","year":"2001","unstructured":"Lowe HC, Fahmy RG, Kavurma MM, et al.: Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis. Circ Res 2001, 89:670\u2013677.","journal-title":"Circ Res"},{"key":"81_CR30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9440(10)65189-9","volume":"155","author":"FS Santiago","year":"1999","unstructured":"Santiago FS, Atkins DG, Khachigian LM: Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1\/NGFI-A-dependent. Am J Pathol 1999, 155:897\u2013905.","journal-title":"Am J Pathol"},{"key":"81_CR31","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/15215","volume":"5","author":"FS Santiago","year":"1999","unstructured":"Santiago FS, Lowe HC, Kavurma MM, et al.: New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 1999, 5:1264\u20131269.","journal-title":"Nat Med"},{"key":"81_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0898-6568(00)00096-6","volume":"12","author":"C Li","year":"2000","unstructured":"Li C, Xu Q: Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 2000, 12:435\u2013445.","journal-title":"Cell Signal"},{"key":"81_CR33","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/sj.gt.3301590","volume":"8","author":"H Yasumoto","year":"2001","unstructured":"Yasumoto H, Kim S, Zhan Y, et al.: Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Gene Ther 2001, 8:1682\u20131689.","journal-title":"Gene Ther"},{"key":"81_CR34","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/01.RES.0000023200.19316.D5","volume":"90","author":"JD Ahn","year":"2002","unstructured":"Ahn JD, Morishita R, Kaneda Y, et al.: Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ Res 2002, 90:1325\u20131332.","journal-title":"Circ Res"},{"key":"81_CR35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1050-1738(03)00081-1","volume":"13","author":"DH Gorski","year":"2003","unstructured":"Gorski DH, Walsh K: Control of vascular cell differentiation by homeobox transcription factors. Trends Cardiovasc Med 2003, 13:213\u2013220.","journal-title":"Trends Cardiovasc Med"},{"key":"81_CR36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/PL00008193","volume":"436","author":"M Bergwerff","year":"2000","unstructured":"Bergwerff M, Gittenberger-de Groot AC, Wisse LJ, et al.: Loss of function of the Prx1 and Prx2 homeobox genes alters architecture of the great elastic arteries and ductus arteriosus. Virchows Arch 2000, 436:12\u201319.","journal-title":"Virchows Arch"},{"key":"81_CR37","first-page":"2409","volume":"36","author":"O Chisaka","year":"1991","unstructured":"Chisaka O: Functional analysis of mouse Hox genes by gene targeting. Tanpakushitsu Kakusan Koso 1991, 36:2409\u20132417.","journal-title":"Tanpakushitsu Kakusan Koso"},{"key":"81_CR38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1097-0177(199701)208:1<34::AID-AJA4>3.0.CO;2-2","volume":"208","author":"ML Kirby","year":"1997","unstructured":"Kirby ML, Hunt P, Wallis K, Thorogood P: Abnormal patterning of the aortic arch arteries does not evoke cardiac malformations. Dev Dyn 1997, 208:34\u201347.","journal-title":"Dev Dyn"},{"key":"81_CR39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/(SICI)1097-4644(20000801)78:2<210::AID-JCB4>3.0.CO;2-Z","volume":"78","author":"K Bostrom","year":"2000","unstructured":"Bostrom K, Tintut Y, Kao SC, et al.: HOXB7 overexpression promotes differentiation of C3H10T1\/2 cells to smooth muscle cells. J Cell Biochem 2000, 78:210\u2013221.","journal-title":"J Cell Biochem"},{"key":"81_CR40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/sj.gt.3300893","volume":"6","author":"H Perlman","year":"1999","unstructured":"Perlman H, Luo Z, Krasinski K, et al.: Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis. Gene Ther 1999, 6:758\u2013763.","journal-title":"Gene Ther"},{"key":"81_CR41","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1101\/gad.11.13.1674","volume":"11","author":"RC Smith","year":"1997","unstructured":"Smith RC, Branellec D, Gorski DH, et al.: p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev 1997, 11:1674\u20131689.","journal-title":"Genes Dev"},{"key":"81_CR42","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4161\/cc.4.11.2129","volume":"4","author":"SY Fuchs","year":"2005","unstructured":"Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T: Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle 2005, 4:1522\u20131539.","journal-title":"Cell Cycle"},{"key":"81_CR43","doi-asserted-by":"crossref","unstructured":"Grant SF, Thorleifsson G, Reynisdottir I, et al.: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, In press.","DOI":"10.1038\/ng1732"},{"key":"81_CR44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000104012.40720.c4","volume":"24","author":"X Wang","year":"2004","unstructured":"Wang X, Adhikari N, Li Q, et al.: The role of [beta]-transducin repeat-containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004, 24:85\u201390.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR45","doi-asserted-by":"crossref","first-page":"H2376","DOI":"10.1152\/ajpheart.01173.2003","volume":"287","author":"X Wang","year":"2004","unstructured":"Wang X, Adhikari N, Li Q, Hall JL: LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004, 287:H2376-H2383.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"81_CR46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/hh0302.104466","volume":"90","author":"X Wang","year":"2002","unstructured":"Wang X, Xiao Y, Mou Y, et al.: A role for the beta-catenin\/T-cell factor signaling cascade in vascular remodeling. Circ Res 2002, 90:340\u2013347.","journal-title":"Circ Res"},{"key":"81_CR47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.HYP.29.1.366","volume":"29","author":"KK Griendling","year":"1997","unstructured":"Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW: Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997, 29:366\u2013373.","journal-title":"Hypertension"},{"key":"81_CR48","doi-asserted-by":"crossref","first-page":"24684","DOI":"10.1074\/jbc.272.39.24684","volume":"272","author":"MB Marrero","year":"1997","unstructured":"Marrero MB, Schieffer B, Li B, et al.: Role of Janus kinase\/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997, 272:24684\u201324690.","journal-title":"J Biol Chem"},{"key":"81_CR49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.RES.87.12.1195","volume":"87","author":"B Schieffer","year":"2000","unstructured":"Schieffer B, Luchtefeld M, Braun S, et al.: Role of NAD(P)H oxidase in angiotensin II-induced JAK\/STAT signaling and cytokine induction. Circ Res 2000, 87:1195\u20131201.","journal-title":"Circ Res"},{"key":"81_CR50","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1074\/jbc.M312571200","volume":"279","author":"C Tang","year":"2004","unstructured":"Tang C, Vaughan AM, Oram JF: Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J Biol Chem 2004, 279:7622\u20137628.","journal-title":"J Biol Chem"},{"key":"81_CR51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vph.2005.08.021","volume":"43","author":"K Grote","year":"2005","unstructured":"Grote K, Luchtefeld M, Schieffer B: JANUS under stress\u2014role of JAK\/STAT signaling pathway in vascular diseases. Vascul Pharmacol 2005, 43:357\u2013363.","journal-title":"Vascul Pharmacol"},{"key":"81_CR52","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.ATV.20.10.2175","volume":"20","author":"KK Griendling","year":"2000","unstructured":"Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000, 20:2175\u20132183.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-0115(00)00136-1","volume":"91","author":"KK Griendling","year":"2000","unstructured":"Griendling KK, Ushio-Fukai M: Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000, 91:21\u201327.","journal-title":"Regul Pept"},{"key":"81_CR54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-2143(98)90019-1","volume":"132","author":"KK Griendling","year":"1998","unstructured":"Griendling KK, Ushio-Fukai M: Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998, 132:9\u201315.","journal-title":"J Lab Clin Med"},{"key":"81_CR55","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","volume":"101","author":"B Schieffer","year":"2000","unstructured":"Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al.: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000, 101:1372\u20131378.","journal-title":"Circulation"},{"key":"81_CR56","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.biocel.2005.01.009","volume":"37","author":"JD Kakisis","year":"2005","unstructured":"Kakisis JD, Pradhan S, Cordova A, et al.: The role of STAT-3 in the mediation of smooth muscle cell response to cyclic strain. Int J Biochem Cell Biol 2005, 37:1396\u20131406.","journal-title":"Int J Biochem Cell Biol"},{"key":"81_CR57","first-page":"2404","volume":"63","author":"K Chida","year":"2003","unstructured":"Chida K, Hara T, Hirai T, et al.: Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res 2003, 63:2404\u20132408.","journal-title":"Cancer Res"},{"key":"81_CR58","doi-asserted-by":"crossref","first-page":"H937","DOI":"10.1152\/ajpheart.00877.2003","volume":"287","author":"M Mayr","year":"2004","unstructured":"Mayr M, Chung YL, Mayr U, et al.: Loss of PKC-delta alters cardiac metabolism. Am J Physiol Heart Circ Physiol 2004, 287:H937-H945.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"81_CR59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.RES.0000156903.37007.d1","volume":"96","author":"M Andrassy","year":"2005","unstructured":"Andrassy M, Belov D, Harja E, et al.: Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. Circ Res 2005, 96:476\u2013483.","journal-title":"Circ Res"},{"key":"81_CR60","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1172\/JCI200112902","volume":"108","author":"M Leitges","year":"2001","unstructured":"Leitges M, Mayr M, Braun U, et al.: Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J Clin Invest 2001, 108:1505\u20131512.","journal-title":"J Clin Invest"},{"key":"81_CR61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/jpet.301.1.15","volume":"301","author":"H Ju","year":"2002","unstructured":"Ju H, Nerurkar S, Sauermelch CF, et al.: Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury. J Pharmacol Exp Ther 2002, 301:15\u201320.","journal-title":"J Pharmacol Exp Ther"},{"key":"81_CR62","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1161\/01.ATV.20.12.2521","volume":"20","author":"N Ohashi","year":"2000","unstructured":"Ohashi N, Matsumori A, Furukawa Y, et al.: Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2000, 20:2521\u20132526.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR63","doi-asserted-by":"crossref","first-page":"10454","DOI":"10.1073\/pnas.180316397","volume":"97","author":"JS Mudgett","year":"2000","unstructured":"Mudgett JS, Ding J, Guh-Siesel L, et al.: Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A 2000, 97:10454\u201310459.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"81_CR64","doi-asserted-by":"crossref","first-page":"10454","DOI":"10.1128\/MCB.25.23.10454-10464.2005","volume":"25","author":"VA Beardmore","year":"2005","unstructured":"Beardmore VA, Hinton HJ, Eftychi C, et al.: Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 2005, 25:10454\u201310464.","journal-title":"Mol Cell Biol"},{"key":"81_CR65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mi.4.6.8","volume":"4","author":"TM Seasholtz","year":"2004","unstructured":"Seasholtz TM, Brown JH: RHO Signaling in vascular diseases. Mol Interv 2004, 4:348\u2013357.","journal-title":"Mol Interv"},{"key":"81_CR66","unstructured":"von Ballmoos MW, Dubler D, Mirlacher M, et al.: Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients. Arterioscler Thromb Vasc Biol 2005, In press."},{"key":"81_CR67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1152\/physiolgenomics.00181.2002","volume":"15","author":"SR Archacki","year":"2003","unstructured":"Archacki SR, Angheloiu G, Tian XL, et al.: Identification of new genes differentially expressed in coronary artery disease by expression profiling. Physiol Genomics 2003, 15:65\u201374.","journal-title":"Physiol Genomics"},{"key":"81_CR68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/bbrc.1999.1129","volume":"262","author":"N Negoro","year":"1999","unstructured":"Negoro N, Hoshiga M, Seto M, et al.: The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells. Biochem Biophys Res Commun 1999, 262:211\u2013215.","journal-title":"Biochem Biophys Res Commun"},{"key":"81_CR69","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.101.17.2030","volume":"101","author":"N Sawada","year":"2000","unstructured":"Sawada N, Itoh H, Ueyama K, et al.: Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 2000, 101:2030\u20132033.","journal-title":"Circulation"},{"key":"81_CR70","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/01.CIR.103.2.284","volume":"103","author":"R Shibata","year":"2001","unstructured":"Shibata R, Kai H, Seki Y, et al.: Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 2001, 103:284\u2013289.","journal-title":"Circulation"},{"key":"81_CR71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.ATV.0000105053.46994.5B","volume":"24","author":"Y Matsumoto","year":"2004","unstructured":"Matsumoto Y, Uwatoku T, Oi K, et al.: Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 2004, 24:181\u2013186.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR72","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.ATV.20.11.2351","volume":"20","author":"K Miyata","year":"2000","unstructured":"Miyata K, Shimokawa H, Kandabashi T, et al.: Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol 2000, 20:2351\u20132358.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR73","doi-asserted-by":"crossref","first-page":"H1744","DOI":"10.1152\/ajpheart.2000.278.6.H1744","volume":"278","author":"Y Eto","year":"2000","unstructured":"Eto Y, Shimokawa H, Hiroki J, et al.: Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am J Physiol Heart Circ Physiol 2000, 278:H1744-H1750.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"81_CR74","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000099062.55042.9A","volume":"93","author":"Z Mallat","year":"2003","unstructured":"Mallat Z, Gojova A, Sauzeau V, et al.: Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 2003, 93:884\u2013888.","journal-title":"Circ Res"},{"key":"81_CR75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/hy0202.103271","volume":"39","author":"C Kataoka","year":"2002","unstructured":"Kataoka C, Egashira K, Inoue S, et al.: Important role of Rhokinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 2002, 39:245\u2013250.","journal-title":"Hypertension"},{"key":"81_CR76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0167-5273(02)00588-0","volume":"91","author":"C Herdeg","year":"2003","unstructured":"Herdeg C, Fitzke M, Oberhoff M, et al.: Effects of atorvastatin on in-stent stenosis in normo- and hypercholesterolemic rabbits. Int J Cardiol 2003, 91:59\u201369.","journal-title":"Int J Cardiol"},{"key":"81_CR77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/hh1701.096614","volume":"89","author":"W Ni","year":"2001","unstructured":"Ni W, Egashira K, Kataoka C, et al.: Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res 2001, 89:415\u2013421.","journal-title":"Circ Res"},{"key":"81_CR78","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00109-004-0602-8","volume":"82","author":"M Hayashi","year":"2004","unstructured":"Hayashi M, Lee JD: Role of the BMK1\/ERK5 signaling pathway: lessons from knockout mice. J Mol Med 2004, 82:800\u2013808.","journal-title":"J Mol Med"},{"key":"81_CR79","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1074\/jbc.271.28.16586","volume":"271","author":"J Abe","year":"1996","unstructured":"Abe J, Kusuhara M, Ulevitch RJ, et al.: Big mitogenactivated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 1996, 271:16586\u201316590.","journal-title":"J Biol Chem"},{"key":"81_CR80","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1073\/pnas.142293999","volume":"99","author":"CP Regan","year":"2002","unstructured":"Regan CP, Li W, Boucher DM, et al.: Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl Acad Sci U S A 2002, 99:9248\u20139253.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"81_CR81","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/73550","volume":"24","author":"J Yang","year":"2000","unstructured":"Yang J, Boerm M, McCarty M, et al.: Mekk3 is essential for early embryonic cardiovascular development. Nat Genet 2000, 24:309\u2013313.","journal-title":"Nat Genet"},{"key":"81_CR82","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.RES.0000168802.43528.e1","volume":"96","author":"X Pi","year":"2005","unstructured":"Pi X, Garin G, Xie L, et al.: BMK1\/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circ Res 2005, 96:1145\u20131151.","journal-title":"Circ Res"},{"key":"81_CR83","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1074\/jbc.M009286200","volume":"276","author":"C Yan","year":"2001","unstructured":"Yan C, Luo H, Lee JD, et al.: Molecular cloning of mouse ERK5\/BMK1 splice variants and characterization of ERK5 functional domains. J Biol Chem 2001, 276:10870\u201310878.","journal-title":"J Biol Chem"},{"key":"81_CR84","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI200419890","volume":"113","author":"M Hayashi","year":"2004","unstructured":"Hayashi M, Kim SW, Imanaka-Yoshida K, et al.: Targeted deletion of BMK1\/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest 2004, 113:1138\u20131148.","journal-title":"J Clin Invest"},{"key":"81_CR85","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.276.5317.1404","volume":"276","author":"Q Lin","year":"1997","unstructured":"Lin Q, Schwarz J, Bucana C, Olson EN: Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997, 276:1404\u20131407.","journal-title":"Science"},{"key":"81_CR86","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00018-005-5253-6","volume":"62","author":"G Sumara","year":"2005","unstructured":"Sumara G, Belwal M, Ricci R: \u201cJnking\u201d atherosclerosis. Cell Mol Life Sci 2005, 62:2487\u20132494.","journal-title":"Cell Mol Life Sci"},{"key":"81_CR87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0896-6273(00)80727-8","volume":"22","author":"CY Kuan","year":"1999","unstructured":"Kuan CY, Yang DD, Samanta Roy DR, et al.: The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999, 22:667\u2013676.","journal-title":"Neuron"},{"key":"81_CR88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0925-4773(99)00213-0","volume":"89","author":"K Sabapathy","year":"1999","unstructured":"Sabapathy K, Jochum W, Hochedlinger K, et al.: Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 1999, 89:115\u2013124.","journal-title":"Mech Dev"},{"key":"81_CR89","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.1101909","volume":"306","author":"R Ricci","year":"2004","unstructured":"Ricci R, Sumara G, Sumara I, et al.: Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004, 306:1558\u20131561.","journal-title":"Science"},{"key":"81_CR90","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.286.5443.1374","volume":"286","author":"G Pages","year":"1999","unstructured":"Pages G, Guerin S, Grall D, et al.: Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 1999, 286:1374\u20131377.","journal-title":"Science"},{"key":"81_CR91","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jb\/mvh078","volume":"135","author":"K Kuida","year":"2004","unstructured":"Kuida K, Boucher DM: Functions of MAP kinases: insights from gene-targeting studies. J Biochem (Tokyo) 2004, 135:653\u2013656.","journal-title":"J Biochem (Tokyo)"},{"key":"81_CR92","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2004.05.019","volume":"176","author":"T Senokuchi","year":"2004","unstructured":"Senokuchi T, Matsumura T, Sakai M, et al.: Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis 2004, 176:233\u2013245.","journal-title":"Atherosclerosis"},{"key":"81_CR93","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","volume":"103","author":"CD Dumitru","year":"2000","unstructured":"Dumitru CD, Ceci JD, Tsatsanis C, et al.: TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway. Cell 2000, 103:1071\u20131083.","journal-title":"Cell"},{"key":"81_CR94","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1093\/emboj\/cdf478","volume":"21","author":"AG Eliopoulos","year":"2002","unstructured":"Eliopoulos AG, Dumitru CD, Wang CC, et al.: Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 2002, 21:4831\u20134840.","journal-title":"EMBO J"},{"key":"81_CR95","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1093\/emboj\/cdg386","volume":"22","author":"AG Eliopoulos","year":"2003","unstructured":"Eliopoulos AG, Wang CC, Dumitru CD, Tsichlis PN: Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J 2003, 22:3855\u20133864.","journal-title":"EMBO J"},{"key":"81_CR96","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1146\/annurev.biochem.68.1.965","volume":"68","author":"TO Chan","year":"1999","unstructured":"Chan TO, Rittenhouse SE, Tsichlis PN: AKT\/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999, 68:965\u20131014.","journal-title":"Annu Rev Biochem"},{"key":"81_CR97","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1074\/jbc.274.14.9133","volume":"274","author":"D Brodbeck","year":"1999","unstructured":"Brodbeck D, Cron P, Hemmings BA: A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J Biol Chem 1999, 274:9133\u20139136.","journal-title":"J Biol Chem"},{"key":"81_CR98","doi-asserted-by":"crossref","first-page":"29550","DOI":"10.1074\/jbc.M104633200","volume":"276","author":"D Brodbeck","year":"2001","unstructured":"Brodbeck D, Hill MM, Hemmings BA: Two splice variants of protein kinase B gamma have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl-terminal hydrophobic domain. J Biol Chem 2001, 276:29550\u201329558.","journal-title":"J Biol Chem"},{"key":"81_CR99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2004-869595","volume":"4","author":"DH Walter","year":"2004","unstructured":"Walter DH, Dimmeler S, Zeiher AM: Effects of statins on endothelium and endothelial progenitor cell recruitment. Semin Vasc Med 2004, 4:385\u2013393.","journal-title":"Semin Vasc Med"},{"key":"81_CR100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mca.0000131572.14521.8a","volume":"15","author":"DH Walter","year":"2004","unstructured":"Walter DH, Zeiher AM, Dimmeler S: Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coronary Artery Dis 2004, 15:235\u2013242.","journal-title":"Coronary Artery Dis"},{"key":"81_CR101","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1101\/gad.913901","volume":"15","author":"WS Chen","year":"2001","unstructured":"Chen WS, Xu PZ, Gottlob K, et al.: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001, 15:2203\u20132208.","journal-title":"Genes Dev"},{"key":"81_CR102","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","volume":"292","author":"H Cho","year":"2001","unstructured":"Cho H, Mu J, Kim JK, et al.: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728\u20131731.","journal-title":"Science"},{"key":"81_CR103","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.1189704","volume":"18","author":"C Daly","year":"2004","unstructured":"Daly C, Wong V, Burova E, et al.: Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev 2004, 18:1060\u20131071.","journal-title":"Genes Dev"},{"key":"81_CR104","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.ATV.0000156288.70849.26","volume":"25","author":"KW Park","year":"2005","unstructured":"Park KW, Kim DH, You HJ, et al.: Activated forkhead transcription factor inhibits neointimal hyperplasia after angioplasty through induction of p27. Arterioscler Thromb Vasc Biol 2005, 25:742\u2013747.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR105","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","volume":"24","author":"EL Greer","year":"2005","unstructured":"Greer EL, Brunet A: FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005, 24:7410\u20137425.","journal-title":"Oncogene"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-006-0081-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-006-0081-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-006-0081-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:35:31Z","timestamp":1559432131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-006-0081-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1007\/s11883-006-0081-1","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}